Chamomile for Skin Healing

Skin Healing — scientific infographic poster

Topical chamomile has the deepest evidence base of any traditional herbal skin remedy. The most cited study is Patzelt-Wenczler and Ponce-Pöschl 2000, a randomized, partially double-blind half-side comparison of a standardized German chamomile cream against 0.5% hydrocortisone and a placebo cream in atopic eczema. After 2 weeks the chamomile cream showed a mild superiority over 0.5% hydrocortisone but only a marginal difference from the placebo cream; the study came from the cream's maker. Unlike hydrocortisone, chamomile cream is not a steroid. The active anti-inflammatory components are alpha-bisabolol (the dominant sesquiterpenoid in chamomile essential oil, a direct skin-soothing terpene used widely in cosmetic preparations) and chamazulene (the deep-blue azulene pigment formed during steam distillation, a 5-lipoxygenase inhibitor that reduces leukotriene-mediated inflammation). Additional evidence supports topical chamomile for episiotomy wound healing, postpartum perineal care, and oral mucositis from chemotherapy and radiation, and chamomile has a long traditional use for minor diaper rash. Practitioners use it as a steroid-free option for chronic mild-to-moderate inflammatory skin conditions where long-term steroid use would be problematic.


Table of Contents

  1. The Topical Tradition (Standardized Creams, Roman vs German Chamomile)
  2. Alpha-Bisabolol: The Skin-Soothing Sesquiterpenoid
  3. Chamazulene: The Anti-Inflammatory Azulene Pigment
  4. The 1985 and 2000 Eczema Trials vs Hydrocortisone
  5. Episiotomy and Postpartum Perineal Wound Healing
  6. Oral Mucositis (Chemotherapy and Radiation)
  7. Diaper Rash and Pediatric Skin Care
  8. Wound Healing and Post-Surgical Use
  9. Topical Preparations and Application
  10. Cautions (Contact Dermatitis, Asteraceae Allergy)
  11. Key Research Papers
  12. Connections
  13. Featured Videos

The Topical Tradition (Standardized Creams, Roman vs German Chamomile)

The European topical-chamomile tradition is centuries deep. The standard German pharmaceutical preparation is a standardized chamomile cream, a 2% chamomile extract cream that has been a pharmacy-shelf staple in German-speaking Europe for decades. The British, French, Italian, and Eastern European pharmacopoeias each include analogous standardized preparations. In the US, chamomile-based cosmetic and over-the-counter (OTC) topical products are widespread but more variable in standardization and active content.

Two species are conflated in the common name "chamomile" and warrant distinction:

When the herbal literature, the European Medicines Agency (EMA) monograph, the German Commission E, or modern clinical trials refer to topical chamomile, they essentially always mean German chamomile. The two species are not interchangeable for therapeutic purposes — Roman chamomile is more of a fragrance herb than a clinical anti-inflammatory.

Back to Table of Contents

Alpha-Bisabolol: The Skin-Soothing Sesquiterpenoid

Alpha-bisabolol is a monocyclic sesquiterpene alcohol, the dominant component of German chamomile essential oil (typically 25–65% of the oil, depending on chemotype and growing conditions). It is the principal anti-inflammatory and skin-soothing component for topical use. The pharmacology has been extensively characterized in dermatologic models:

Bisabolol is so reliably skin-soothing that it has become a standard ingredient in commercial cosmetic and over-the-counter topical formulations, often synthesized rather than chamomile-extracted because synthetic bisabolol is purer and more consistent. The chamomile origin is incidental to the commercial use — bisabolol stands on its own pharmacology. When you see "bisabolol" on the ingredient label of a calming facial cream or a baby wash, the active is the same molecule that gives chamomile cream its clinical effect.

An important distinction in the bisabolol literature: German chamomile contains the natural (−)-alpha-bisabolol form (enantiomer), while a racemic mixture of both mirror-image forms is sold for some industrial applications. Some dermatologic preparations state that they use (−)-alpha-bisabolol.

Back to Table of Contents

Chamazulene: The Anti-Inflammatory Azulene Pigment

Chamazulene is the deep indigo-blue tricyclic azulene that gives German chamomile essential oil its famous inky-blue color. The molecule is unusual in plant chemistry — the parent terpene azulenes are deep blue rather than the green or colorless typical of other sesquiterpenes. Chamazulene is not present in the intact plant tissue; it forms during the steam-distillation process from the sesquiterpene lactone precursor matricin, which undergoes thermal rearrangement at distillation temperatures to release chamazulene.

The pharmacology:

The combination of bisabolol (mast cell, NF-kB, iNOS) and chamazulene (5-lipoxygenase, leukotrienes, oxidative stress) hits at least two non-overlapping arms of the cutaneous inflammatory cascade. The synergy explains why whole-extract topical chamomile preparations outperform isolated single components in dermatologic models, and supports the traditional preference for whole-flower or whole-oil topical use rather than purified single-component cosmetic ingredients.

Back to Table of Contents

The 1985 and 2000 Eczema Trials vs Hydrocortisone

Atopic dermatitis (eczema) affects approximately 10% of children and 3% of adults in the developed world. The mainstay of pharmacologic management is topical corticosteroids, used in graduated potency from over-the-counter 0.5–1% hydrocortisone (low potency) up to prescription super-potent clobetasol. Topical steroids work, but chronic use carries meaningful risks: skin atrophy, telangiectasia, perioral dermatitis, tachyphylaxis, and hypothalamic-pituitary-adrenal-axis suppression with extensive use. This is why steroid-free creams have been studied.

Two German trials of a standardized chamomile-extract cream are often merged into one in summaries. They were separate studies with different designs and different results.

Aertgeerts and colleagues (1985) studied 161 patients with inflammatory skin disease on the hands, forearms and lower legs who had first been treated with a steroid cream (0.1% difluocortolone valerate). In a 3-to-4-week maintenance phase, each patient used a different cream on each side of the body: the chamomile cream against 0.25% hydrocortisone, 0.75% fluocortin butyl ester (another steroid) or 5% bufexamac (a non-steroidal anti-inflammatory cream). The chamomile cream worked about as well as 0.25% hydrocortisone and better than 5% bufexamac and 0.75% fluocortin butyl ester. This trial had no placebo cream.

Patzelt-Wenczler and Ponce-Pöschl (2000) ran a randomized, partially double-blind, half-side comparison in people with medium-degree atopic eczema. The abstract does not give the number of patients. The study came from the cream's maker: its first author was listed at the company. Design:

Results:

The interpretation needs some nuance: 0.5% hydrocortisone is the lowest-potency topical steroid, used for mild eczema only, and in the 2000 trial the chamomile cream did only marginally better than its own cream base. Results against low-dose hydrocortisone say nothing about the high-potency steroids used for severe disease. The appeal of chamomile cream for mild-to-moderate eczema is that it is not a steroid, so it does not carry the skin-thinning risk of long-term steroid use.

Practitioners who use chamomile cream describe it as a steroid-free option for chronic mild atopic dermatitis, particularly on the face (where topical steroid use is limited by skin thinning and eye complications) and for areas that need repeated treatment over weeks to months. In standard dermatology care, severe eczema flares are treated with high-potency topical steroids; chamomile is then described as a maintenance and steroid-sparing option during the taper. For more on the disease, see our Eczema page.

Back to Table of Contents

Episiotomy and Postpartum Perineal Wound Healing

Episiotomy and perineal lacerations are common complications of vaginal delivery, affecting a large majority of first-time mothers and a meaningful fraction of multiparous deliveries. Recovery is often painful and slow, and is complicated by the obligate exposure of the wound to urine and stool. Topical preparations that accelerate healing and reduce pain are clinically valuable in the postpartum period.

Several controlled trials have examined topical chamomile preparations for episiotomy and perineal wound healing in postpartum women. Aggregate findings:

The mechanism likely combines the bisabolol anti-inflammatory effect on damaged tissue, the chamazulene leukotriene-modulating effect on the local inflammatory response, modest antibacterial activity against perineal flora (reducing infection risk), and the warm-moist application's general physical benefit on wound closure.

Traditional practice: post-delivery sitz baths with strong chamomile tea infusion (1 cup dried chamomile flowers infused in 4 cups boiling water for 15 minutes, then strained and added to a basin of warm bath water), taken two to three times daily for the first one to two weeks postpartum. Pre-made chamomile sitz-bath sachets are also sold by herbal-pharmacy retailers, and cream is often applied after the sitz bath.

Back to Table of Contents

Oral Mucositis (Chemotherapy and Radiation)

Oral mucositis — severe inflammation and ulceration of the oral mucosa — is one of the most distressing toxicities of cancer chemotherapy and head-and-neck radiation therapy. Severe oral mucositis can require parenteral nutrition, opioid pain management, and treatment dose reduction. The conventional management includes meticulous oral hygiene, ice chip prophylaxis, and a variety of topical agents (lidocaine, sucralfate suspension, "magic mouthwash" combinations).

Chamomile mouthwash has been studied as an adjunct for chemotherapy and radiation oral mucositis with mixed but generally encouraging results:

Where chamomile mouthwash is used, it is used as a low-cost add-on to standard oral mucositis care, not in place of ice-chip cooling during high-dose chemotherapy, a dental check before head-and-neck radiation, or opioid pain medicines for severe established mucositis. Standardized preparations or freshly brewed strong chamomile tea, swished and spat three to five times daily, are the typical application.

Back to Table of Contents

Diaper Rash and Pediatric Skin Care

Chamomile-containing baby washes and creams have a long European tradition for routine pediatric skin care and for diaper rash. The evidence here is traditional and practical rather than from trials:

The main reported risk of topical chamomile in children is allergy: infants and children with known or suspected Asteraceae (daisy-family) allergy can react to it. The atopic-dermatitis context is particularly relevant — children with eczema are at elevated risk of cross-sensitization to topical herbal allergens including chamomile. A patch test on a small area is the traditional check when a child has any history of atopic disease.

Pediatric chamomile bath is a centuries-old European tradition for calming fussy babies and treating mild skin irritation. The traditional method adds one cup of strong chamomile tea infusion to the bath water. The fragrance has a calming effect on caregivers as well, which is not a trivial benefit during a difficult bedtime.

Back to Table of Contents

Wound Healing and Post-Surgical Use

Beyond episiotomy, topical chamomile has been studied in a variety of wound-healing contexts:

The mechanism across these wound contexts is consistent: the bisabolol-chamazulene anti-inflammatory pair, modest antibacterial activity reducing wound bioburden, mucosal-barrier and keratinocyte support during re-epithelialization. The effect is supportive rather than dramatic; chamomile is a useful adjunct, not a substitute for primary wound care.

Back to Table of Contents

Topical Preparations and Application

The usual check with any new chamomile topical is a patch test on the inner forearm before larger areas are covered: a small amount is applied, left for 24 hours, and the skin is checked for redness, itching or rash. People with atopic disease or known plant allergies are the ones most likely to react.

Back to Table of Contents

Cautions (Contact Dermatitis, Asteraceae Allergy)

Back to Table of Contents

Key Research Papers

  1. Patzelt-Wenczler R, Ponce-Pöschl E (2000). Proof of efficacy of Kamillosan(R) cream in atopic eczema. European Journal of Medical Research, 5(4):171-175. — PubMed PMID: 10799352
  2. Albring M, Albrecht H, Alcorn G, Lücker PW (1983). The measuring of the antiinflammatory effect of a compound on the skin of volunteers. Methods and Findings in Experimental and Clinical Pharmacology, 5(8):575-577. — PubMed PMID: 6664158
  3. Glowania HJ, Raulin C, Swöboda M (1987). Effect of chamomile on wound healing — a clinical double-blind study. Z Hautkr, 62(17):1262, 1267-1271. — PubMed PMID: 3318194
  4. Mazokopakis EE et al. (2005). Wild chamomile (Matricaria recutita L.) mouthwashes in methotrexate-induced oral mucositis. Phytomedicine, 12(1-2):25-27. (A single case report.) — PubMed PMID: 15693704
  5. Fidler P et al. (1996). Prospective evaluation of a chamomile mouthwash for prevention of 5-FU-induced oral mucositis. Cancer, 77(3):522-525. — PubMed PMID: 8630960
  6. Reuter J, Jocher A, Stump J, Grossjohann B, Franke G, Schempp CM (2008). Investigation of the anti-inflammatory potential of Aloe vera gel (97.5%) in the ultraviolet erythema test. Skin Pharmacology and Physiology, 21(2):106-110. (An aloe vera study; it did not test chamomile.) — PubMed PMID: 18253066
  7. Kamatou GPP, Viljoen AM (2010). A review of the application and pharmacological properties of alpha-bisabolol and alpha-bisabolol-rich oils. Journal of the American Oil Chemists' Society, 87:1-7. — doi:10.1007/s11746-009-1483-3
  8. Safayhi H et al. (1994). Chamazulene: an antioxidant-type inhibitor of leukotriene B4 formation. Planta Medica, 60(5):410-413. — PubMed PMID: 7997466
  9. Srivastava JK, Shankar E, Gupta S (2010). Chamomile: A herbal medicine of the past with bright future. Molecular Medicine Reports, 3(6):895-901. — PubMed PMID: 21132119
  10. Aertgeerts P, Albring M, Klaschka F, Nasemann T, Patzelt-Wenczler R, Rauhut K, Weigl B (1985). Comparative testing of Kamillosan cream and steroidal (0.25% hydrocortisone, 0.75% fluocortin butyl ester) and non-steroidal (5% bufexamac) dermatologic agents in maintenance therapy of eczematous diseases. Z Hautkr, 60(3):270-277. — PubMed PMID: 3158124
  11. Aradmehr M, Azhari S, Ahmadi S, Azmoude E (2017). The effect of chamomile cream on episiotomy pain in primiparous women: a randomized clinical trial. Journal of Caring Sciences, 6(1):19-28. — PubMed PMID: 28299294
  12. Sharifi-Ardani M, Yekefallah L, Asefzadeh S, Nassiri-Asl M (2017). Efficacy of topical chamomile on the incidence of phlebitis due to an amiodarone infusion in coronary care patients: a double-blind, randomized controlled trial. Journal of Integrative Medicine, 15(5):373-378. — PubMed PMID: 28844214
  13. Maleki M, Mardani A, Manouchehri M, Ashghali Farahani M, Vaismoradi M, Glarcher M (2023). Effect of chamomile on the complications of cancer: a systematic review. Integrative Cancer Therapies, 22:15347354231164600. — PubMed PMID: 37052390
  14. Lee CC, Chen YW, Kang YN, Chen JH, Chen C, Lu CY, Huang TW, Gautama MSN (2024). Efficacy of natural products in preventing oral mucositis resulting from cancer therapies: a network meta-analysis of randomized controlled trials. Critical Reviews in Oncology/Hematology, 199:104373. — PubMed PMID: 38710295

PubMed Topic Searches

  1. PubMed: Chamomile and atopic dermatitis
  2. PubMed: Chamomile episiotomy and wound healing
  3. PubMed: Chamomile and oral mucositis
  4. PubMed: Alpha-bisabolol anti-inflammatory skin
  5. PubMed: Chamazulene and 5-lipoxygenase
  6. PubMed: Standardized chamomile cream eczema studies

Back to Table of Contents

Connections

Back to Table of Contents